ORIGINAL RESEARCH
Accepted on 05 May 2025
Hypoxia-induced tRF-3 Thr-CGT promotes hepatocellular carcinoma progression via mitochondrial energy metabolism remodeling dependent on the mtDNA-translation mechanism
doi 10.3389/fphar.2025.1549373
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- The Role of Tumor Microenvironment in Malignant Progression and Target Validation
The Role of Tumor Microenvironment in Malignant Progression and Target Validation
1,665
Total downloads
6,669
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 03 Mar 2025
Multi-omics analysis of the dynamic role of STAR+ cells in regulating platinum-based chemotherapy responses and tumor microenvironment in serous ovarian carcinoma
doi 10.3389/fphar.2025.1545762
- 972 views
ORIGINAL RESEARCH
Published on 25 Feb 2025
Fenvalerate exposure induces AKT/AMPK-dependent alterations in glucose metabolism in hepatoma cells
doi 10.3389/fphar.2025.1540567
- 864 views
ORIGINAL RESEARCH
Published on 04 Feb 2025
Exploring the anti-metastatic potential of sunitinib and novel analogs in colorectal cancer: insights into HIF-1α mediated metastasis
doi 10.3389/fphar.2025.1520881
- 751 views
MINI REVIEW
Published on 11 Dec 2024
Cellular components of tumor microenvironment: understanding their role in lymphatic metastasis of tumors
doi 10.3389/fphar.2024.1463538
- 967 views
OPINION
Published on 16 Sep 2024
Cholesterol metabolism: a positive target to revoke the function of exhausted CAR-NK cells in tumor microenvironment
doi 10.3389/fphar.2024.1440869
- 913 views
- 1 citation
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore